xIPOmeter
Freenome
Freenome is an innovative company focused on early cancer detection through advanced blood testing. Their technology integrates multiomics analysis and machine learning to spot patterns associated with cancer, using a mix of tumor and non-tumor biomarkers. Their goal is to produce easily accessible tests for various cancer types, improving early detection and treatment.
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
*** - To view the data, please log into your account or create a new one.
Company valuation calculator
To calculate, specify one of the parameters
News related to Freenome6
FreenomeFreenome CEO Mike Nolan exits cancer test maker - San Francisco ...
Freenome appointed co-founder Riley Ennis as head of an interim office of the CEO. He will be assisted by former NeoGenomics CEO Douglas VanOort. Ennis has been ...
https://www.bizjournals.com/sanfrancisco/news/2024/09/25/cancer-test-freenome-ceo-exit-mike-nolan.htmlFreenomeFreenome Announces CEO Transition
Freenome is a biotechnology company pioneering an early cancer detection platform. (PRNewsfoto/Freenome. News provided by. Freenome Holdings, Inc....
https://www.prnewswire.com/news-releases/freenome-announces-ceo-transition-302259012.htmlFreenomeCanaccord positive on Exact, Guardant after Freenome data ...
Canaccord positive on Exact, Guardant after Freenome data. See the rest of the story here. Theflyonthewall.com provides the latest financial news as it ...
https://pro.thestreet.com/thefly-newsbreaks/exas-gh-canaccord-positive-on-exact-guardant-after-freenome-dataFreenomeExact Sciences Stock, A Cathie Wood's Play, Surges On Freenome's ...
Freenome is working on a blood-based test to detect colorectal cancer. Overall, Freenome's test proved roughly as specific as Exact Sciences' stool-based test, ...
https://www.investors.com/news/technology/exact-sciences-stock-cologuard-freenome-colon-cancer-detection/FreenomeFreenome Announces Topline Results for PREEMPT CRC® to ...
Freenome is breaking barriers to early cancer detection with a suite of blood tests built on its multiomics platform. The company recognizes that no single ...
https://www.prnewswire.com/news-releases/freenome-announces-topline-results-for-preempt-crc-to-validate-the-first-version-of-its-blood-based-test-for-the-early-detection-of-colorectal-cancer-302105203.html
Show more (1)Investors23
Andreessen Horowitz
Third Kind Venture Capital
Founders Fund
Data Collective DCVC
Polaris Partners
S28 Capital
AME Cloud Ventures
Charles River Associates
Allen & Company
GV
Asset Management Ventures (AMV)
Innovation Endeavors
CRV
Verily
Section 32
Artis Ventures (AV)
T. Rowe Price
BrightEdge Fund
Roche Venture Fund
Kaiser Permanente Ventures
RA Capital Management
Perceptive Advisors
Loxbridge Research